medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2011, Number 4

<< Back Next >>

Rev Invest Clin 2011; 63 (4)

Dermatoses in patients with acute myeloid and lymphoid leukemia. Cohort follow-up in a tertiary care hospital

Sánchez-Hernández C, Crespo-Solís E, Rosas-López A, Archer-Dubon C, Orozco-Topete R

Language: Spanish
References: 37
Page: 353-360
PDF size: 160.38 Kb.


ABSTRACT

Introduction. Cutaneous manifestations in patients with acute leukemia (AL) cover a broad spectrum, including those due to leukemia per se, to chemotherapy and other drugs and those inherent to hospital care. Material and methods. This is a cohort study in a tertiary hospital setting where the development of dermatoses was followed for 2 years in 22 patients with the diagnosis of AL. Results. During the study, all patients developed some type of dermatosis, mostly due to chemotherapy.


REFERENCES

  1. Linker C. Blood. En: Tierney L, McPhee S, Papadakis M. Current Medical Diagnosis and Treatment. 44th. Ed. Estados Unidos: Mc Graw Hill; 2006, p. 463-517.

  2. Epstein P, Alguire P. Acute leukemias. In: MKSAP (Medical Knowledge Self-Assessment Program). Hematology and Oncology. Estados Unidos: Baylor University Medical Center; 2006, p. 13-18.

  3. Piette W. Hematologic diseases. In: Freedberg I, Eisen A, Wolff K, Austen K, Goldsmith L, Katz S (eds.). Fitzpatrick´s Dermatology in General Medicine. 6th. Ed. Estados Unidos: Mc Graw Hill; 2003, p. 1523-37.

  4. Smoller B, Winfield H. Other lymphoproliferative and myeloproliferative diseases. In: Bolognia J, Jorizzo J, Rapini R (eds.). Dermatology. 2nd. Ed. Estados Unidos: Mosby; 2007, p. 1887-96.

  5. Fitzpatrick J. Mucocutaneous complications of antineoplasic therapy. In: Freedberg I, Eisen A, Wolff K, Austen K, Goldsmith L, Katz S (eds.). Fitzpatrick’s Dermatology in General Medicine. 6th. Ed. Estados Unidos: Mc Graw Hill; 2003, p. 1337-47.

  6. Revuz J, Valeyrie-Allonore L. Drug reactions. In: Bolognia J, Jorizzo J, Rapini R (eds.). Dermatology. 2nd. Ed. Estados Unidos: Mosby Elsevier; 2007, p. 301-20.

  7. Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40(3): 367-98.

  8. McKenna J, Leiferman K. Dermatologic drug reactions. Immunol Allergy Clin 2004; 24: 399-423.

  9. Chabner B, Allegra C, Curt G, Calabresi P. Fármacos antineoplásicos. En: Hardman J, Limbird L, Molinoff P, Ruddon R, Goodman A (eds.) Las bases farmacológicas de la terapéutica. 9a. Ed. México: Mc Graw Hill Interamericana; 1996, p. 1309-67.

  10. Frías G, Hierro S. Manifestaciones cutáneas en pacientes con alteraciones hematológicas. Derma Rev Mex 2007; 51(4): 142-8.

  11. Buitrón-Santiago N, Arteaga-Ortiz L, Rosas-López A, Aguayo A, López-Karpovitch X, Crespo-Solís E. Experiencia del INCMNSZ en pacientes adultos con leucemia mieloide aguda. Cohorte 2003-2008. Rev Invest Clin 2010; 62(2): 1-10.

  12. Arteaga-Ortiz L, Buitrón-Santiago N, Rosas-López A, Rosas-Arzate G, Armengolt-Jiménez A, Aguayo A, et al. Experiencia del INCMNSZ en pacientes adultos con leucemia linfoide aguda. Cohorte 2003-2007 con esquemas de tratamiento Hiper-CVAD y Protocolo 0195. Rev Invest Clin 2008; 60(6): 459-69.

  13. Vardiman J, et al. Introduction and overview of the classification of the myeloid neoplasms. In: Swerdlow S, et al. (eds.) WHO classification of tumours. Pathology and genetics. Tumours of haematopoietic and lymphoid tissues. 4th. Ed. Suiza: WHO Press; 2008, p. 18-30.

  14. Rodríguez H, Juárez L. Leucemia cutánea, comunicación de un caso y revisión de la literatura. Derma Rev Mex 2007; 51: 20-4.

  15. Goor Y, Goor O, Michalewitcz R, Cabili S. Acute myeloid leukemia presenting as obstructive jaundice. J Clin Gastroenterol 2002; 34(4): 485-6.

  16. Wandroo F, Murray J, Mutimer D, Hubscher S. Acute myeloid leukemia presenting as cholestatic hepatitis. J Clin Pathol 2004; 57(5): 544-5.

  17. Coutsouvelis J, Corallo C. The management of prolonged, isolated hyperbilirubinemia following cytarabine-based chemotherapy for acute myeloid leukaemia. J Oncol Pharm Pract 2009; 15(2): 107-10.

  18. Crespo E, Díaz P, Austrich E, Cervera I. Leucemia aguda. Recomendaciones para el paciente durante su enfermedad y tratamiento. México: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán.

  19. Dunagin WG. Clinical toxicity of chemotherapeutic agents: dermatologic toxicity. Semin Oncol 1982; 9(1): 14-22.

  20. Hood A. Cutaneous side effects of cancer chemotherapy. Med Clin North Am 1986; 70(1): 187-209.

  21. Koo L, Davis S, Suttle A, Friedman C, Bartlett-Pandite L. Incidence of chemotherapy- induced alopecia by chemotherapy regimen: a review of published randomized trials. Proc Am Soc Clin Oncol 2002; 21 (abst. 2876).

  22. Schilli M, Paus R, Menrad A. Reduction of intrafolicullar apoptosis in chemotherapy- induced alopecia by topical calcitriol- analogs. J Invest Dermatol 1998; 111(4): 598-604.

  23. Dave S, Thappa D. Peculiar pattern of nail pigmentation following cyclophosphamide therapy. Dermat Online J 9(3):14. Available from: http://dermatology.cdlib.org/93/case_reports/nails/thappa.html

  24. Cancelas J. Chemotherapy-induced neutrophilic eccrine hidradenitis in Acute Myeloid Leukemia. Act Haematol 1992; 87: 167-8.

  25. Roustan G, Salas C, Cabrera R, Simón A. Neutrophilic eccrine hidradenitis unassociated with chemotherapy in a patient with acute myelogenous leukemia. Int J Dermatol 2001; 40: 33- 152.

  26. Jansen T, Plewig G. What´s new in acne inversa (alias hidradenitis suppurativa)? J Eur Acad Dermatol Venereol 2000; 14: 342-3.

  27. Alikhan A, Lynch P, Eisen D. Hidradenitis suppurativa, a comprehensive review. J Am Acad Dermatol 2009; 60(4): 539-61.

  28. Musa M, Katakkar S, Khaliq A. Anorectal and perianal complications of hematologic malignant neoplasms. Can J Surg 1975; 18(6): 579-83.

  29. Sehdev M, Dowling M, Seal S, Stearns M. Perianal and anorectal complications in leukemia. Cancer 1973; 31(1): 149-52.

  30. North J, Weber T, Rodríguez-Bigas M, Meropol N, Petrelli N. The management of infectious and noninfectious anorectal complications in patients with leukemia. J Am Coll Surg 1996; 183(4): 322-8.

  31. Glenn J, Cotton D, Wesley R, Pizzo P. Anorectal infections in patients with malignant diseases. Rev Infect Dis 1988; 10(1): 42-52.

  32. Styczynsli J, et al. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after Steam Cell Transplantation: guidelines from the Second European Conference of Infections in Leukemia. Bone Marrow Trans 2009; 43(10): 757-70.

  33. Ramsey P, Fife K, Hackman R, Meyers J, Corey L. Herpes simplex virus pneumonia: clinical, virologic, and pathologic features in 20 patients. Ann Intern Med 1982; 97: 813-20.

  34. Kaufman B, Gandhi S, Louie E, Rizzi R, Illei P. Herpes simplex virus hepatitis: case reports and review. Clin Infect Dis 1997; 24: 334-8.

  35. Mommeja-Marin H, Lafaurie M, Scieux C, Galicier L, Oksenhendler E, Molina J. Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin Infect Dis 2003; 37: 1527-33.

  36. Arteaga L, et al. Experiencia del INCMNSZ en pacientes adultos con leucemia linfoide aguda. Cohorte 2003-2007 con esquemas de tratamiento Hiper- CVAD y protocolo 0195. Rev Inv Clin 2008; 60: 458-69.

  37. Rivera-Martínez N. Complicaciones Infecciosas y Mortalidad asociada en pacientes con neutropenia grave y fiebre sin profilaxis antimicrobiana inducida por quimioterapia para leucemia linfoblástica aguda atendidos en el Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán [Tesis de especialidad en Infectología]. 2008.




2020     |     www.medigraphic.com